Syphilis in Pregnancy: A Comprehensive Guide for Expectant Parents

Table of Contents

• What is Syphilis and Why is it a Concern in Pregnancy?
• Risks and Complications: Mother, Fetus, and Newborn
• Diagnostic Testing and Screening for Syphilis
• Treatment Guidelines During Pregnancy
• Follow-Up, Partner Management, and Prevention
• Frequently Asked Questions (FAQ)

Navigating a pregnancy involves many health considerations, and understanding sexually transmitted infections (STIs) is a crucial part of prenatal care. Syphilis in pregnancy is a serious but treatable condition that, if left undiagnosed, can lead to devastating outcomes for both the pregnant person and the baby. This guide will walk you through everything you need to know: from how syphilis is transmitted and the critical importance of prenatal screening, to the specific treatment protocols and follow-up care required to ensure a healthy pregnancy and newborn. Knowledge is your first line of defense.

What is Syphilis and Why is it a Concern in Pregnancy?

Syphilis is a bacterial infection caused by Treponema pallidum. It is primarily spread through direct contact with a syphilis sore during vaginal, anal, or oral sex. The infection progresses through stages (primary, secondary, latent, and tertiary), each with different symptoms. However, it's possible to have syphilis and show no obvious signs for years, which is why screening is so vital.

When a person is pregnant, the syphilis bacteria can cross the placenta and infect the developing fetus at any stage of pregnancy or during delivery. This is known as congenital syphilis. The risk of transmission is high; without treatment, up to 80% of pregnancies in people with syphilis can result in adverse outcomes, including miscarriage, stillbirth, preterm birth, or a baby born with congenital syphilis. The good news is that syphilis in pregnancy is preventable and curable with timely penicillin treatment, which is why public health guidelines emphasize universal screening.

"Prenatal screening for syphilis is one of the most effective public health interventions we have. A simple blood test and a course of penicillin can prevent lifelong disability and tragedy. It should be a non-negotiable part of early prenatal care for every pregnant person." – Illustrative expert opinion from a maternal-fetal medicine specialist.

Risks and Complications: Mother, Fetus, and Newborn

Untreated syphilis during pregnancy poses severe risks at every level. Understanding these potential outcomes underscores the urgency of screening and treatment.

Maternal Risks

While the immediate focus is often on the baby, syphilis still poses significant health risks to the pregnant person. If left untreated, the infection can progress to later stages, potentially damaging the heart, brain, nerves, eyes, blood vessels, liver, bones, and joints. Pregnancy does not accelerate the course of syphilis, but the presence of the infection creates a high-risk obstetric situation.

Fetal and Neonatal Risks (Congenital Syphilis)

Congenital syphilis is a severe, disabling, and often life-threatening infection. The consequences depend largely on how long the maternal infection was present and untreated during gestation.

• Early Pregnancy: Syphilis in the first trimester can lead to miscarriage, stillbirth, or non-immune hydrops fetalis (severe fetal swelling).
• Later Pregnancy & Newborn Period: A live-born infant may have symptoms at birth or develop them within the first few months of life. These can include:
  • Rash, particularly on the palms and soles
  • Fever, severe anemia, and enlarged liver/spleen
  • Snuffles (a runny nose that can be bloody)
  • Bone abnormalities and pain
  • Neurological issues (meningitis, seizures, developmental delays)
  • Hearing loss, vision impairment, and dental deformities later in childhood

It is estimated that congenital syphilis cases have more than tripled in many regions over the past decade, making awareness and proactive prenatal care more critical than ever.

Diagnostic Testing and Screening for Syphilis

Diagnosis of syphilis in pregnancy relies on blood tests, as physical symptoms may be absent or mistaken for other conditions. The testing strategy is two-tiered to ensure accuracy.

The Two-Tier Testing Approach

1. Nontreponemal Tests (RPR or VDRL): These tests measure antibodies that are not specific to syphilis but are produced in response to the infection. They are reported as a titer (e.g., 1:8, 1:32). The titer level correlates with disease activity and is used to monitor treatment response. A fourfold decrease in titer (e.g., from 1:32 to 1:8) indicates successful treatment.
2. Treponemal Tests (TP-PA, EIA, CIA): These tests detect antibodies specific to the T. pallidum bacterium. They confirm whether a positive nontreponemal test is a true syphilis infection or a false positive. Once positive, these tests usually remain positive for life, even after successful treatment.

Screening Recommendations in Prenatal Care

Universal screening is the standard of care. The CDC and other global health bodies recommend:

• First Prenatal Visit: All pregnant people should be screened for syphilis at the first prenatal visit.
• Third Trimester & Delivery: Repeat screening at 28 weeks and again at delivery is recommended for people at high risk or living in communities with high syphilis rates. Some areas mandate repeat testing for all pregnant people.
• Any Pregnancy Loss: Testing should be performed in cases of stillbirth.

This aggressive screening approach is necessary because a person can acquire syphilis at any point during their pregnancy, even after a negative first test.

Treatment Guidelines During Pregnancy

The treatment for syphilis in pregnancy is very specific and must be managed by a healthcare provider. Penicillin G is the only therapy known to effectively treat the fetus and prevent congenital syphilis.

Stage of Syphilis	Recommended Treatment in Pregnancy	Key Considerations
Primary, Secondary, or Early Latent (<1 year duration)	Benzathine penicillin G, 2.4 million units intramuscularly (IM) in a single dose.	This is the first-line, definitive treatment. It cures the mother and prevents transmission to the fetus if given >30 days before delivery.
Late Latent (>1 year duration), Latent of Unknown Duration, or Tertiary	Benzathine penicillin G, 2.4 million units IM once per week for 3 consecutive weeks (total 7.2 million units).	Longer treatment is required for infections of longer duration. Adherence to all three doses is critical.

Penicillin Allergy and Other Management Considerations

Penicillin Allergy: This is a major challenge in pregnancy. There is no proven alternative to penicillin for treating the fetus. If a pregnant person has a penicillin allergy, they must be referred for penicillin allergy skin testing and, if positive, desensitized followed by immediate penicillin treatment. Tetracycline and doxycycline, which are alternatives for non-pregnant adults, are not safe for use in pregnancy.

HIV Co-infection: Pregnant people with both syphilis and HIV should receive the same penicillin regimen as those without HIV. However, they require even closer serologic and clinical monitoring, as treatment failure may be more common.

"The rule is absolute: penicillin is the only choice for treating syphilis in a pregnant person. If there's a history of allergy, we don't just switch drugs—we work with allergy specialists to safely deliver penicillin through desensitization. The health of the baby depends on it." – Illustrative expert opinion from an infectious disease consultant.

Follow-Up, Partner Management, and Prevention

Treatment is not the end of the process. Careful follow-up ensures cure and prevents reinfection.

Post-Treatment Follow-Up and Titers

After treatment, nontreponemal test titers (RPR/VDRL) should be checked to document an adequate response.

• Repeat titers are typically drawn at 1, 3, 6, 12, and 24 months after treatment.
• A successful response is a fourfold (or greater) decline in titer by 6-12 months. For example, a titer that drops from 1:32 to 1:8 shows effective treatment.
• In pregnancy, titers are often checked monthly until delivery to ensure they are not rising, which would indicate treatment failure or reinfection.

Management of Sex Partners

To prevent the "ping-pong" effect of reinfection, all recent sex partners must be evaluated, tested, and treated presumptively. Partners from within the last 90 days (for primary syphilis) or the last year (for secondary/early latent syphilis) should be contacted and treated immediately, even before their test results are back. This is a cornerstone of public health management.

Prevention for Future Pregnancies

With proper treatment and follow-up, future pregnancies are not at risk from a past, cured syphilis infection. The key preventive measures for any pregnancy are:

1. Consistent and correct condom use with any partner whose STI status is unknown.
2. Open communication with partners about sexual health and testing history.
3. Ensuring timely and complete prenatal care with all recommended screenings.

Taking charge of your sexual health is empowering. For resources and products that can support your wellness journey, explore our curated selection of sexual health products and vibrators, designed with safety and pleasure in mind.

Frequently Asked Questions About Syphilis in Pregnancy

I was treated for syphilis years ago. Will it affect my current pregnancy?

Will my baby need treatment after birth?